Literature DB >> 22083459

Protective efficacy of coenzyme Q10 against DDVP-induced cognitive impairments and neurodegeneration in rats.

B K Binukumar1, Nidhi Gupta, Aditya Sunkaria, Ramesh Kandimalla, W Y Wani, D R Sharma, Amanjit Bal, Kiran Dip Gill.   

Abstract

The present study was carried out to elucidate the effects of coenzyme Q(10) (CoQ(10)) against cognitive impairments induced by dichlorvos (DDVP). We have previously shown organophosphate, DDVP-induced impairments in neurobehavioral indices viz. rota rod, passive avoidance, and water maze tests. In addition to this, we have also reported that chronic DDVP exposure leads to decreased mitochondrial electron transfer activities of cytochrome oxidase along with altered mitochondrial complexes I-III activity. Administration of CoQ(10) (4.5 mg/kg, i.p. for 12 weeks prior to DDVP administration daily) to DDVP-treated rats improved cognitive performance in passive avoidance task and Morris water maze test. Furthermore, CoQ(10) treatment also reduced oxidative stress (as evident by reduced malondialdehyde, decreased ROS and increased Mn-SOD activity) in DDVP-treated rats' hippocampus region, along with enhanced activity of complexes I-III and complex IV. Electron microscope studies of rat hippocampus mitochondria revealed that CoQ(10) administration leads to near normal physiology of mitochondria with well-defined cristae compared with DDVP-treated animals where enlarged mitochondria with distorted cristae are observed. CoQ(10) administration also attenuated neuronal damage in hippocampus as evident from histopathological studies. These results demonstrate the beneficial effects of CoQ(10) against organophosphate-induced cognitive impairments and hippocampal neuronal degeneration. © Springer Science+Business Media, LLC 2011

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22083459     DOI: 10.1007/s12640-011-9289-0

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  43 in total

1.  Pharmacological and acute toxicological comparisons of triflupromazine and chlorpromazine.

Authors:  J J PIALA; J P HIGH; G L HASSERT; J C BURKE; B N CRAVER
Journal:  J Pharmacol Exp Ther       Date:  1959-09       Impact factor: 4.030

2.  Chronic neurological effects of organophosphate pesticides.

Authors:  K Steenland
Journal:  BMJ       Date:  1996-05-25

3.  CoQ10 fails to protect brain against focal and global ischemia in rats.

Authors:  H Li; G Klein; P Sun; A M Buchan
Journal:  Brain Res       Date:  2000-09-15       Impact factor: 3.252

4.  Repeated exposures to subthreshold doses of chlorpyrifos in rats: hippocampal damage, impaired axonal transport, and deficits in spatial learning.

Authors:  A V Terry; J D Stone; J J Buccafusco; D W Sickles; A Sood; M A Prendergast
Journal:  J Pharmacol Exp Ther       Date:  2003-04       Impact factor: 4.030

5.  Redox status of plasma coenzyme Q10 indicates elevated systemic oxidative stress in Parkinson's disease.

Authors:  Makoto Sohmiya; Makoto Tanaka; Nyou Wei Tak; Makoto Yanagisawa; Yutaka Tanino; Yoko Suzuki; Koichi Okamoto; Yorihiro Yamamoto
Journal:  J Neurol Sci       Date:  2004-08-30       Impact factor: 3.181

6.  Paraquat induces oxidative stress, neuronal loss in substantia nigra region and parkinsonism in adult rats: neuroprotection and amelioration of symptoms by water-soluble formulation of coenzyme Q10.

Authors:  Mallika Somayajulu-Niţu; Jagdeep K Sandhu; Jerome Cohen; Marianna Sikorska; T S Sridhar; Anca Matei; Henryk Borowy-Borowski; Siyaram Pandey
Journal:  BMC Neurosci       Date:  2009-07-27       Impact factor: 3.288

7.  Impaired mitochondrial energy metabolism and neuronal apoptotic cell death after chronic dichlorvos (OP) exposure in rat brain.

Authors:  Pushpinder Kaur; Bishan Radotra; Ranjana W Minz; K D Gill
Journal:  Neurotoxicology       Date:  2007-08-07       Impact factor: 4.294

8.  Developments of a water-maze procedure for studying spatial learning in the rat.

Authors:  R Morris
Journal:  J Neurosci Methods       Date:  1984-05       Impact factor: 2.390

9.  An anthropological approach to the evaluation of preschool children exposed to pesticides in Mexico.

Authors:  E A Guillette; M M Meza; M G Aquilar; A D Soto; I E Garcia
Journal:  Environ Health Perspect       Date:  1998-06       Impact factor: 9.031

View more
  7 in total

Review 1.  Is Alzheimer's disease a Type 3 Diabetes? A critical appraisal.

Authors:  Ramesh Kandimalla; Vani Thirumala; P Hemachandra Reddy
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2016-08-25       Impact factor: 5.187

2.  Potential Protective Effect of Coenzyme Q10 on Doxorubicin-Induced Neurotoxicity and Behavioral Disturbances in Rats.

Authors:  Nilsel Okudan; Muaz Belviranlı; Tuğba Sezer
Journal:  Neurochem Res       Date:  2022-01-03       Impact factor: 3.996

Review 3.  Multiple faces of dynamin-related protein 1 and its role in Alzheimer's disease pathogenesis.

Authors:  Ramesh Kandimalla; P Hemachandra Reddy
Journal:  Biochim Biophys Acta       Date:  2015-12-17

Review 4.  The role of oxidative stress in organophosphate and nerve agent toxicity.

Authors:  Jennifer N Pearson; Manisha Patel
Journal:  Ann N Y Acad Sci       Date:  2016-07-02       Impact factor: 5.691

5.  Coenzyme Q10 protects against burn-induced mitochondrial dysfunction and impaired insulin signaling in mouse skeletal muscle.

Authors:  Harumasa Nakazawa; Kazuhiro Ikeda; Shohei Shinozaki; Shingo Yasuhara; Yong-Ming Yu; J A Jeevendra Martyn; Ronald G Tompkins; Tomoko Yorozu; Satoshi Inoue; Masao Kaneki
Journal:  FEBS Open Bio       Date:  2019-01-19       Impact factor: 2.693

6.  Mitochondrial complex I inhibition as a possible mechanism of chlorpyrifos induced neurotoxicity.

Authors:  Mohamed Salama; Doaa El-Morsy; Mohamed El-Gamal; Osama Shabka; Wael My Mohamed
Journal:  Ann Neurosci       Date:  2014-07

7.  The Effect of Organophosphate Exposure on Neuronal Cell Coenzyme Q10 Status.

Authors:  Nadia Turton; Robert A Heaton; Fahima Ismail; Sioned Roberts; Sian Nelder; Sue Phillips; Iain P Hargreaves
Journal:  Neurochem Res       Date:  2020-04-18       Impact factor: 3.996

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.